Tag: PROAC

Phase I study initiated to evaluate a new precision oral anticoagulant...

The first-in-human phase I trial will take place in Australia for Verseon’s PROAC (PRecision Oral AntiCoagulant) VE-1902, which has successfully completed regulatory toxicology studies...